1. A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab. (30th November 2018) Authors: Galluzzo, M.; D'Adamio, S.; Campione, E.; Mazzilli, S.; Bianchi, L.; Talamonti, M. Journal: Journal of dermatological treatment Issue: Volume 29(2018)Supplement 1 Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab. (1st August 2020) Authors: D'Adamio, S.; Massaro, A.; Biocca, S.; Bianchi, L.; Talamonti, M.; Galluzzo, M. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 6(2020) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab. (30th May 2020) Authors: D'Adamio, S.; Massaro, A.; Biocca, S.; Bianchi, L.; Talamonti, M.; Galluzzo, M. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 6(2020) Page Start: 809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A safety evaluation of guselkumab for the treatment of psoriasis. Issue 7 (3rd July 2018) Authors: Galluzzo, M.; D'Adamio, S.; Campione, E.; Bianchi, L.; Talamonti, M. Journal: Expert opinion on drug safety Issue: Volume 17:Issue 7(2018) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0346 Investigation of alexithymia in patients affected by rheumatoid and psoriatic arthritis: cross-sectional observation. (12th June 2018) Authors: Fonti, G.L.; Chimenti, M.S.; Conigliaro, P.; Hitaj, J.; Galluzzo, M.; Talamonti, M.; Kroegler, B.; Greco, E.; Perricone, R. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis. (19th May 2017) Authors: Galluzzo, M.; Talamonti, M.; Perino, F.; Servoli, S.; Giordano, D.; Chimenti, S.; De Simone, C.; Peris, K. Journal: Journal of dermatological treatment Issue: Volume 28:Number 4(2017) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Brodalumab for the treatment of psoriasis. (1st December 2016) Authors: Galluzzo, M.; D'adamio, S.; Bianchi, L.; Talamonti, M. Journal: Expert review of clinical immunology Issue: Volume 12:Number 12(2016) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature. (2nd June 2020) Authors: Caldarola, G.; Pirro, F.; Di Stefani, A.; Talamonti, M.; Galluzzo, M.; D'Adamio, S.; Magnano, M.; Bernardini, N.; Malagoli, P.; Bardazzi, F.; Potenza, C.; Bianchi, L.; Peris, K.; De Simone, C. Journal: Expert opinion on biological therapy Issue: Volume 20:Number 6(2020) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0464 Long-Term Efficacy of Ustekinumab Treatment in Patients Affected by Psoriatic Arthritis Previously Treated with TNF Inhibitors. (15th July 2016) Authors: Chimenti, M.S.; Triggianese, P.; Ortolan, A.; Tonelli, M.; Talamonti, M.; Costa, L.; Caso, F.; Teoli, M.; Galluzzo, M.; Ramonda, R.; Scarpa, R.; Punzi, L.; Perricone, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. High‐resolution HLA typing identifies a new 'super responder' subgroup of HLA‐C*06:02‐positive psoriatic patients: HLA‐C*06:02/HLA‐C*04, in response to ustekinumab. (20th May 2019) Authors: Talamonti, M.; D'Adamio, S.; Galluccio, T.; Andreani, M.; Pastorino, R.; Egan, C.G.; Bianchi, L.; Galluzzo, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: e364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗